Ocular Therapeutix, Inc. Receives IDE Approval to Conduct a Pivotal Clinical Trial for ReSure™ Sealant
Ocular Therapeutix, Inc. announced today that it has received IDE approval from the U.S. Food and Drug Administration to conduct
Pioneering Medical Innovations
Ocular Therapeutix, Inc. announced today that it has received IDE approval from the U.S. Food and Drug Administration to conduct
Novel Design of Chocolate is Aimed at Improving Patient Outcomes PLEASANTON, Calif., Dec. 21, 2011 /PRNewswire/ — TriReme Medical, Inc.
October 28, 2011 – Claret Medical announces the CE Mark approval of MontageTM, a new embolic protection system to address
August 17, 2011 – Claret Medical receives CE Mark approval for it’s CE Pro System, the company’s first ever dual
MOUNTAIN VIEW, Calif., May 6, 2011 /PRNewswire/ — Hotspur Technologies, Inc. announced today that it has received CE Mark approval
Study Results Support Improved Patient Comfort with the Mynx Device Mountain View, California (March 3, 2011) – AccessClosure, Inc., the
Mountain View, CA – January 18, 2011 – Hotspur Technologies, Inc. announced today that Dr. Greg Sampognaro, Interventional Cardiologist at
Plugs achieved 100% retention and demonstrated sustained levels of moxifloxacin throughout the 10-day treatment period. Ocular Therapeutix, Inc. announced today